Concepedia

Author

Michaela Feodoroff

University of HelsinkiORCID

Also Known As

Michaela Feodoroff, Michaela J. Feodoroff

26

Publications

359

Citations

9

H-Index

14

Concepts

All Affiliations

University of HelsinkiUniversity of Naples Federico IIInstitute for Molecular Medicine FinlandScience for Life LaboratoryKarolinska Institutet
MF

About

Michaela Feodoroff is an author at University of Helsinki specializing in cancer research, cell culture, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

15

2

Medicine

1

1

15

3

Biomedical Engineering

1

1

15

4

Cell Biology

1

1

15

5

Pharmacology

1

1

15

Michaela Feodoroff

×

8

Publications

197

Citations

8

H-Index

YearCitations

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro,

Journal for ImmunoTherapy of Cancer

2021

51

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

Sara Feola, Jacopo Chiaro, Beatriz Martins,

eLife

2022

39

PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification

Sara Feola, Markus Haapala, Karita Peltonen,

ACS Nano

2021

30

Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

Sara Feola, Salvatore Russo, Beatriz Martins,

Frontiers in Immunology

2022

21

GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses

Firas Hamdan, Beatriz Martins, Michaela Feodoroff,

Molecular Therapy — Methods & Clinical Development

2021

17

Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT)

Michaela Feodoroff, Piia Mikkonen, Laura Turunen,

SLAS DISCOVERY

2023

15

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors

Jacopo Chiaro, Gabriella Antignani, Sara Feola,

Nature Communications

2023

13

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors

Sara Feola, Firas Hamdan, Salvatore Russo,

Journal for ImmunoTherapy of Cancer

2024

11

Page 1